Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / QDEL - Fulgent Genetics: Sell This Covid-19 Stock Before Its Earnings Slump

QDEL - Fulgent Genetics: Sell This Covid-19 Stock Before Its Earnings Slump

QuidelOrtho Corp Com
  • Fulgent Genetics has earned a windfall as a leading player in the Covid-19 testing arena.
  • However, that business makes up more than 90% of revenues currently; the rest of Fulgent is rather small.
  • Once Covid-19 goes away, Fulgent's valuation looks extremely stretched; the stock is at 90x estimated 2023 earnings.
  • Fulgent's core business is continuing to improve, but traders have gotten way ahead of themselves due to this short-lived earnings surge.

For further details see:

Fulgent Genetics: Sell This Covid-19 Stock Before Its Earnings Slump
Stock Information
Company Name: QuidelOrtho Corp Com
Stock Symbol: QDEL
Market: NASDAQ
Website: WWW.quidelortho.com
Menu
QDEL QDEL Quote QDEL Short QDEL News QDEL Articles QDEL Message Board
Get QDEL Alerts

News, Short Squeeze, Breakout and More Instantly...